OrganiGram Capital Stock from 2010 to 2024

OGI Stock

USD 1.52 0.01 0.66%

OrganiGram Holdings' Capital Stock is increasing with slightly volatile movements from year to year. Capital Stock is predicted to flatten to about 527.4 M. Capital Stock is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. View All Fundamentals

Capital Stock

First Reported

2010-12-31

Previous Quarter

885.2 M

Current Value

527.4 M

Quarterly Volatility

280.8 M

Credit Downgrade

Yuan Drop

Covid

Check OrganiGram Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OrganiGram Holdings' main balance sheet or income statement drivers, such as Interest Expense of 303.5 K, Selling General Administrative of 59.1 M or Other Operating Expenses of 465.6 M, as well as many indicators such as Price To Sales Ratio of 2.86, Dividend Yield of 0.0 or PTB Ratio of 0.82. OrganiGram financial statements analysis is a perfect complement when working with OrganiGram Holdings Valuation or Volatility modules.

Check out the analysis of OrganiGram Holdings Correlation against competitors.

For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.

Latest OrganiGram Holdings' Capital Stock Growth Pattern

Below is the plot of the Capital Stock of OrganiGram Holdings over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. OrganiGram Holdings' Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in OrganiGram Holdings' overall financial position and show how it may be relating to other accounts over time.

Capital Stock

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Capital Stock

Timeline

OrganiGram Capital Stock Regression Statistics

	Arithmetic Mean	378,928,018
	Geometric Mean	293,620,469
	Coefficient Of Variation	74.12
	Mean Deviation	243,987,622
	Median	157,790,000
	Standard Deviation	280,846,292
	Sample Variance	78874.6T
	Range	727.4M
	R-Value	0.85
	Mean Square Error	24245T
	R-Squared	0.71
	Significance	0.000072
	Slope	53,085,522
	Total Sum of Squares	1104245T

OrganiGram Capital Stock History

	2024	527.4 M
	2023	885.2 M
	2021	769.7 M
	2020	730.8 M
	2019	420.7 M
	2018	318.1 M

Other Fundumenentals of OrganiGram Holdings

Issuance Of Capital Stock

OrganiGram Holdings Capital Stock component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Accounts Payable	Common Stock	Net Tangible Assets	Long Term Debt	Short Term Investments	Long Term Debt Total	Short Long Term Debt	Short Term Debt	Property Plant Equipment	Net Invested Capital	Net Working Capital	Capital Stock	Current Deferred Revenue
Total Assets		0.99	-0.26	-0.55	0.8	0.8	0.97	0.89	0.76	0.99	0.3	0.65	0.75	0.31	0.38	0.96	0.89	0.9	0.76	0.8
Total Stockholder Equity	0.99		-0.39	-0.61	0.85	0.7	0.95	0.89	0.81	0.99	0.16	0.63	0.68	0.22	0.3	0.94	0.91	0.88	0.83	0.83
Net Debt	-0.26	-0.39		0.52	-0.54	0.3	-0.21	-0.35	-0.51	-0.37	0.81	-0.12	0.09	0.69	0.63	-0.15	-0.34	-0.25	-0.58	-0.31
Retained Earnings	-0.55	-0.61	0.52		-0.85	-0.15	-0.55	-0.5	-0.94	-0.64	0.26	-0.39	-0.41	0.09	0.07	-0.46	-0.83	-0.68	-0.91	-0.73
Net Receivables	0.8	0.85	-0.54	-0.85		0.42	0.74	0.83	0.95	0.86	-0.11	0.37	0.51	0.06	0.11	0.77	0.91	0.76	0.91	0.82
Total Liab	0.8	0.7	0.3	-0.15	0.42		0.83	0.66	0.4	0.72	0.78	0.57	0.84	0.58	0.61	0.82	0.61	0.75	0.31	0.48
Total Current Assets	0.97	0.95	-0.21	-0.55	0.74	0.83		0.83	0.75	0.95	0.36	0.72	0.86	0.24	0.3	0.89	0.89	0.95	0.73	0.72
Accounts Payable	0.89	0.89	-0.35	-0.5	0.83	0.66	0.83		0.7	0.88	0.16	0.26	0.6	0.22	0.27	0.87	0.82	0.73	0.7	0.6
Common Stock	0.76	0.81	-0.51	-0.94	0.95	0.4	0.75	0.7		0.84	-0.12	0.52	0.55	0.02	0.06	0.7	0.93	0.83	0.94	0.83
Net Tangible Assets	0.99	0.99	-0.37	-0.64	0.86	0.72	0.95	0.88	0.84		0.17	0.65	0.69	0.24	0.31	0.95	0.92	0.91	0.83	0.84
Long Term Debt	0.3	0.16	0.81	0.26	-0.11	0.78	0.36	0.16	-0.12	0.17		0.25	0.6	0.73	0.71	0.36	0.14	0.28	-0.2	0.06
Short Term Investments	0.65	0.63	-0.12	-0.39	0.37	0.57	0.72	0.26	0.52	0.65	0.25		0.62	0.08	0.14	0.57	0.54	0.75	0.48	0.62
Long Term Debt Total	0.75	0.68	0.09	-0.41	0.51	0.84	0.86	0.6	0.55	0.69	0.6	0.62		0.2	0.22	0.64	0.73	0.87	0.49	0.45
Short Long Term Debt	0.31	0.22	0.69	0.09	0.06	0.58	0.24	0.22	0.02	0.24	0.73	0.08	0.2		0.99	0.48	0.21	0.13	-0.01	0.35
Short Term Debt	0.38	0.3	0.63	0.07	0.11	0.61	0.3	0.27	0.06	0.31	0.71	0.14	0.22	0.99		0.55	0.25	0.18	0.05	0.42
Property Plant Equipment	0.96	0.94	-0.15	-0.46	0.77	0.82	0.89	0.87	0.7	0.95	0.36	0.57	0.64	0.48	0.55		0.82	0.81	0.66	0.81
Net Invested Capital	0.89	0.91	-0.34	-0.83	0.91	0.61	0.89	0.82	0.93	0.92	0.14	0.54	0.73	0.21	0.25	0.82		0.92	0.93	0.83
Net Working Capital	0.9	0.88	-0.25	-0.68	0.76	0.75	0.95	0.73	0.83	0.91	0.28	0.75	0.87	0.13	0.18	0.81	0.92		0.78	0.72
Capital Stock	0.76	0.83	-0.58	-0.91	0.91	0.31	0.73	0.7	0.94	0.83	-0.2	0.48	0.49	-0.01	0.05	0.66	0.93	0.78		0.84
Current Deferred Revenue	0.8	0.83	-0.31	-0.73	0.82	0.48	0.72	0.6	0.83	0.84	0.06	0.62	0.45	0.35	0.42	0.81	0.83	0.72	0.84

Click cells to compare fundamentals

About OrganiGram Holdings Financial Statements

Investors use fundamental indicators, such as OrganiGram Holdings' Capital Stock, to determine how well the company is positioned to perform in the future. Although OrganiGram Holdings' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.

		Last Reported	Projected for Next Year
	Capital Stock	885.2 M	527.4 M

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

When determining whether OrganiGram Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OrganiGram Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organigram Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organigram Holdings Stock:

How To Invest In OrganiGram

Details

Is OrganiGram Stock a good investment?

Details

What is OrganiGram Holdings' Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of OrganiGram Holdings Correlation against competitors.

For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.

You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OrganiGram Holdings. If investors know OrganiGram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.80)

Revenue Per Share

1.835

Quarterly Revenue Growth

(0.14)

Return On Assets

(0.06)

Return On Equity

(0.55)

The market value of OrganiGram Holdings is measured differently than its book value, which is the value of OrganiGram that is recorded on the company's balance sheet. Investors also form their own opinion of OrganiGram Holdings' value that differs from its market value or its book value, called intrinsic value, which is OrganiGram Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OrganiGram Holdings' market value can be influenced by many factors that don't directly affect OrganiGram Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between OrganiGram Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

OrganiGram Capital Stock from 2010 to 2024

Latest OrganiGram Holdings' Capital Stock Growth Pattern

OrganiGram Capital Stock Regression Statistics

OrganiGram Capital Stock History

Other Fundumenentals of OrganiGram Holdings

OrganiGram Holdings Capital Stock component correlations

About OrganiGram Holdings Financial Statements

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY